SCHEMBL3757891

SCHEMBL3757891

C[C@H](Cn1c2ccccc2c2cc(C(N)=O)c(N)nc21)NC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
TSHR P16473 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
GAA P10253 1/20 0.54
ALOX15 P16050 1/20 0.54
ATM Q13315 1/20 0.54
HSD17B10 Q99714 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
RCE1 Q9Y256 1/20 0.48
EEF2K O00418 3/20 0.45
EEF2 P13639 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
APAF1 O14727 1/20 0.37
IKBKB O14920 1/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3442380 1.00 KDM4E (0.54) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL398563 1.00 KDM4E (0.54) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL399310 0.92 KDM4E (0.52) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL10148123 0.90 KDM4E (0.53) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL3759456 0.88 KDM4E (0.43) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL399439 0.87 KDM4E (0.57) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL398291 0.87 KDM4E (0.57) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL10148288 0.87 ATM (0.50) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL10148282 0.86 GAA (0.52) KDM4ETSHRALDH1A1HPGDGAA
SCHEMBL3763230 0.86 HPGD (0.42) KDM4ETSHRALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF CHRM1, CNR1, CXCR1 KDM4E 2021/4885TSHR 1997/4885ALDH1A1 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.